← Leaderboards
Steven Reed
Hdt Bio Corporation
$10,970,058
Attributed
$10,970,058
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.2M · FY2020–22$5M$3.8M$2.5M$1.3M$0
'20
'21
'22
Funding mix
By agency
NIH$10,970,058 · 1
By mechanism
N01$10,970,058 · 1
Top collaborators
No co-investigators on record.
Most similar at Hdt Bio Corporation
Same institution · by research overlap
- Amit Praful Khandhar$5,276,681
- Malcolm S Duthie$710,328
- Bryan Berube$575,195
- Kandyma Sar$1,499,422
Others in their field
Other Emerging Leaders on “Vaccines”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$149,372,007
- Kimberly Smith · Ppd Development Lp$115,671,664
- Kevin Urdahl · Seattle Children'S Hospital$85,664,942
- Yunda Huang · Fred Hutchinson Cancer Center$74,099,786
- Ted Ross · University Of Georgia$71,962,304
Research focus
VaccinesAnimal ModelCategoriesCommunicable DiseasesContractsVaccine DevelopmentAdvanced DevelopmentCovid-19 VaccineDisease OutbreaksEfficacy EvaluationEfficacy TestingEmerging Communicable DiseasesFormulationImmunogenicityNational Institute Of Allergy And Infectious DiseasePriority PathogenResponseSafetyStability TestingToxicologyCovid-19Phase I Clinical Trials